Model
Edge
4D Molecular Therapeutics
0001872280
Filing Type
3
Filing Date
12/10/2025
Updated
12/11/25, 2:13 PM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership